Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Pushes its Boundaries With New Alliance Manager


About a year and a half after its spinout from Affymetrix, Perlegen Sciences signaled an increased push to market its technology by hiring Paul Cusenza as its vice president of alliance management.

Cusenza, 42, who spent the last few years as an independent consultant and worked with Affy two years ago on the decision to spin out the genome-scanning division, says his mandate is to build strong relationships with pharmaceutical companies and other potential partners.

Perlegen’s ability to scan for 1.7 million SNPs across the genome will be the catalyst necessary to draw reluctant pharmas out of their shells, Cusenza contends. For both association studies and pharmacogenomics projects to rescue failed drugs, “I think the outlook is very bullish and very positive,” he says, counting on his ability to convince these companies to listen to the Perlegen pitch. “If you’ve got great science and great technology, then the biggest crime is [if] you don’t communicate it well.”

Some 20 years ago, Cusenza started out working for IBM in sales and marketing. More recently, he was in charge of alliances for Capital One Financial. His engineering background helps him understand Perlegen’s technology, but for the biology knowledge, he relies on reading up on the field and tapping the company’s scientists. “I’m getting my own personal education in this topic and enjoying it very much,” he says.

— Meredith Salisbury

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.